Bilal
Demir
abc,
Lea
Rosselle
c,
Anna
Voronova
c,
Quentin
Pagneux
c,
Audrey
Quenon
d,
Valery
Gmyr
d,
Dorothee
Jary
b,
Nathalie
Hennuyer
e,
Bart
Staels
e,
Thomas
Hubert
d,
Amar
Abderrahmani
c,
Valerie
Plaisance
c,
Valerie
Pawlowski
c,
Rabah
Boukherroub
c,
Severine
Vignoud
*b and
Sabine
Szunerits
*c
aCEA-TECH Region, Department Hauts-de-France, 165 Avenue de Bretagne, Lille 59000, France
bLETI-DTBS, CEA, 17 rue des Martyrs, Grenoble, 38054, France. E-mail: severine.vignoud@cea.fr
cUniv. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 – IEMN, Lille F-59000, France. E-mail: sabine.szunerits@univ-lille.fr
dUniv. Lille, CHU Lille, Inserm, European Genomic Institute of Diabetes (EGID), Institut Pasteur de Lille, UMR 1190, Lille F-59000, France
eUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 – EGID, Lille F-59000, France
First published on 19th February 2025
Expression of concern for ‘Innovative transdermal delivery of insulin using gelatin methacrylate-based microneedle patches in mice and mini-pigs’ by Bilal Demir et al., Nanoscale Horiz., 2022, 7, 174–184, https://doi.org/10.1039/D1NH00596K.
Heather Montgomery
7th February 2025
Managing Editor, Nanoscale Horizons
This journal is © The Royal Society of Chemistry 2025 |